Skip to main content

House committee questions Biogen drug approval process

The FDA's approval process of Biogen's Alzheimer's drug was questioned in a Congressional report released Thursday.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.